Select ingredient
CELLS

Cannabigerol is a potential therapeutic agent in a novel combined therapy for Glioblastoma.
PHYTOTHER RES

CBG ameliorated DNBS-induced colonic inflammation…Furthermore, the combination of FO, CBD, and…CBG resulted in intestinal anti-inflammatory effects.
J. PHARMACOL. EXP. THER.

CBG may have therapeutic potential in treating neurological disorders (e.g. Huntington’s disease, Parkinson’s disease, and multiple sclerosis), [IBD], as well as having antibacterial activity.
MOLECULES

The most promising cannabinoid combination…consisted of [THC], CBG, CBN, and CBD, and displayed favorable dose reduction indices and limited cytotoxicity against the non-cancerous breast cell line.
NAT. PROD. COMMUN.

CBG also reduced acetylcholine-induced contractions in the human bladder.
BR. J. PHARMACOL

Cannabichromene exerts anti-inflammatory actions in activated macrophages…and ameliorates experimental murine colitis.
PHARMACOL. BIOCHEM. BEHAV.

Results of this study show that Delta(9)-THC and…[CBC and CBD] exert antidepressant-like actions.
ACS CHEM NEUROSCI.

Anticonvulsant efficacy was evident with CBC, CBCA, and CBCVA.
MOLECULES

Synergistic interaction was demonstrated between CBC+THC [for cytotoxicity against bladder urothelial carcinoma, the most common urinary system cancer].
J. CLIN. PHARMACOL.

[CBC] antibacterial activity was strong…CBC was superior to phenylbutazone [in anti-inflammatory activity].
Select ingredient
CELLS

Cannabigerol is a potential therapeutic agent in a novel combined therapy for Glioblastoma.
PHYTOTHER RES

CBG ameliorated DNBS-induced colonic inflammation…Furthermore, the combination of FO, CBD, and…CBG resulted in intestinal anti-inflammatory effects.
J. PHARMACOL. EXP. THER.

CBG may have therapeutic potential in treating neurological disorders (e.g. Huntington’s disease, Parkinson’s disease, and multiple sclerosis), [IBD], as well as having antibacterial activity.
MOLECULES

The most promising cannabinoid combination…consisted of [THC], CBG, CBN, and CBD, and displayed favorable dose reduction indices and limited cytotoxicity against the non-cancerous breast cell line.
NAT. PROD. COMMUN.

CBG also reduced acetylcholine-induced contractions in the human bladder.
BR. J. PHARMACOL

Cannabichromene exerts anti-inflammatory actions in activated macrophages…and ameliorates experimental murine colitis.
PHARMACOL. BIOCHEM. BEHAV.

Results of this study show that Delta(9)-THC and…[CBC and CBD] exert antidepressant-like actions.
ACS CHEM NEUROSCI.

Anticonvulsant efficacy was evident with CBC, CBCA, and CBCVA.
MOLECULES

Synergistic interaction was demonstrated between CBC+THC [for cytotoxicity against bladder urothelial carcinoma, the most common urinary system cancer].
J. CLIN. PHARMACOL.

[CBC] antibacterial activity was strong…CBC was superior to phenylbutazone [in anti-inflammatory activity].
Select ingredient
CELLS

Cannabigerol is a potential therapeutic agent in a novel combined therapy for Glioblastoma.
PHYTOTHER RES

CBG ameliorated DNBS-induced colonic inflammation…Furthermore, the combination of FO, CBD, and…CBG resulted in intestinal anti-inflammatory effects.
J. PHARMACOL. EXP. THER.

CBG may have therapeutic potential in treating neurological disorders (e.g. Huntington’s disease, Parkinson’s disease, and multiple sclerosis), [IBD], as well as having antibacterial activity.
MOLECULES

The most promising cannabinoid combination…consisted of [THC], CBG, CBN, and CBD, and displayed favorable dose reduction indices and limited cytotoxicity against the non-cancerous breast cell line.
NAT. PROD. COMMUN.

CBG also reduced acetylcholine-induced contractions in the human bladder.
BR. J. PHARMACOL

Cannabichromene exerts anti-inflammatory actions in activated macrophages…and ameliorates experimental murine colitis.
PHARMACOL. BIOCHEM. BEHAV.

Results of this study show that Delta(9)-THC and…[CBC and CBD] exert antidepressant-like actions.
ACS CHEM NEUROSCI.

Anticonvulsant efficacy was evident with CBC, CBCA, and CBCVA.
MOLECULES

Synergistic interaction was demonstrated between CBC+THC [for cytotoxicity against bladder urothelial carcinoma, the most common urinary system cancer].
J. CLIN. PHARMACOL.

[CBC] antibacterial activity was strong…CBC was superior to phenylbutazone [in anti-inflammatory activity].